Accueil
Norma Biln
Norma Biln
Affiliations
Augurex Life Sciences Corp., Vancouver, British Columbia, Canada.
ORCID: 0000-0003-2164-8044
Publications (3)
Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.
Scandinavian journal of rheumatology
Avec:
M B Raft
,
M L Hetland
,
C H Brahe
,
K Hørslev-Petersen
,
L Midtbøll Ørnbjerg
,
P Junker
,
N Biln
,
K Stengaard-Pedersen
,
M Østergaard
Patient Perspectives on a Digital Mobile Health Application for RA.
Open access rheumatology : research and reviews
Avec:
Simran Chahal
,
Norma Biln
,
Bruce Clarke
Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages.
Arthritis research & therapy
Avec:
Gulzhan Trimova
,
Kaoru Yamagata
,
Shigeru Iwata
,
Shintaro Hirata
,
Tong Zhang
,
Fumi Uemura
,
Minoru Satoh
,
Norma Biln
,
Shingo Nakayamada
,
Walter P Maksymowych
,
Yoshiya Tanaka
Réseau de co-auteurs
M B Raft
1 collaboration
M L Hetland
1 collaboration
C H Brahe
1 collaboration
K Hørslev-Petersen
1 collaboration
L Midtbøll Ørnbjerg
1 collaboration
P Junker
1 collaboration
N Biln
1 collaboration
K Stengaard-Pedersen
1 collaboration
M Østergaard
1 collaboration
Simran Chahal
1 collaboration
Bruce Clarke
1 collaboration
Gulzhan Trimova
1 collaboration
Kaoru Yamagata
1 collaboration
Shigeru Iwata
1 collaboration
Shintaro Hirata
1 collaboration
Tong Zhang
1 collaboration
Fumi Uemura
1 collaboration
Minoru Satoh
1 collaboration
Shingo Nakayamada
1 collaboration
Walter P Maksymowych
1 collaboration
Yoshiya Tanaka
1 collaboration